EARLY PRESCRIPTION OF PLATELET P2Y12 RECEPTOR INHIBITORS TO PATIENTS WITH ACUTE CORONARY SYNDROME: A BENEFIT OR A HARM?
Double antiplatelet therapy, which includes aspirin and platelet P2Y12 receptor inhibitors (hereinafter P2Y12 inhibitor) is the main component of treatment and secondary prevention after ACS. In recent years, the issue of determining whether it is expedient for P2Y12 inhibitors to be early prescribe...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«REMEDIUM GROUP» Ltd.
2018-12-01
|
| Series: | Атеротромбоз |
| Subjects: | |
| Online Access: | https://www.aterotromboz.ru/jour/article/view/168 |
| _version_ | 1797883907618635776 |
|---|---|
| author | Roman M. Shakhnovich |
| author_facet | Roman M. Shakhnovich |
| author_sort | Roman M. Shakhnovich |
| collection | DOAJ |
| description | Double antiplatelet therapy, which includes aspirin and platelet P2Y12 receptor inhibitors (hereinafter P2Y12 inhibitor) is the main component of treatment and secondary prevention after ACS. In recent years, the issue of determining whether it is expedient for P2Y12 inhibitors to be early prescribed to patients with ACS – prior to coronary angiography, when coronary anatomy is unknown – has been widely debated. The review provides comprehensive up-to-date information on this topic based on data from randomized trials, registers, and official clinical guidelines. |
| first_indexed | 2024-04-10T03:59:14Z |
| format | Article |
| id | doaj.art-3d653318ec744cf6a70416306ca51368 |
| institution | Directory Open Access Journal |
| issn | 2307-1109 2658-5952 |
| language | Russian |
| last_indexed | 2024-04-10T03:59:14Z |
| publishDate | 2018-12-01 |
| publisher | «REMEDIUM GROUP» Ltd. |
| record_format | Article |
| series | Атеротромбоз |
| spelling | doaj.art-3d653318ec744cf6a70416306ca513682023-03-13T07:10:42Zrus«REMEDIUM GROUP» Ltd.Атеротромбоз2307-11092658-59522018-12-0102768610.21518/2307-1109-2018-2-76-86148EARLY PRESCRIPTION OF PLATELET P2Y12 RECEPTOR INHIBITORS TO PATIENTS WITH ACUTE CORONARY SYNDROME: A BENEFIT OR A HARM?Roman M. Shakhnovich0Федеральное государственное бюджетное учреждение «Национальный медицинский исследовательский центр кардиологии» Министерства здравоохранения Российской ФедерацииDouble antiplatelet therapy, which includes aspirin and platelet P2Y12 receptor inhibitors (hereinafter P2Y12 inhibitor) is the main component of treatment and secondary prevention after ACS. In recent years, the issue of determining whether it is expedient for P2Y12 inhibitors to be early prescribed to patients with ACS – prior to coronary angiography, when coronary anatomy is unknown – has been widely debated. The review provides comprehensive up-to-date information on this topic based on data from randomized trials, registers, and official clinical guidelines.https://www.aterotromboz.ru/jour/article/view/168острый коронарный синдромингибиторы p2y12-рецепторов тромбоцитовклопидогрелтикагрелорпрасугрел |
| spellingShingle | Roman M. Shakhnovich EARLY PRESCRIPTION OF PLATELET P2Y12 RECEPTOR INHIBITORS TO PATIENTS WITH ACUTE CORONARY SYNDROME: A BENEFIT OR A HARM? Атеротромбоз острый коронарный синдром ингибиторы p2y12-рецепторов тромбоцитов клопидогрел тикагрелор прасугрел |
| title | EARLY PRESCRIPTION OF PLATELET P2Y12 RECEPTOR INHIBITORS TO PATIENTS WITH ACUTE CORONARY SYNDROME: A BENEFIT OR A HARM? |
| title_full | EARLY PRESCRIPTION OF PLATELET P2Y12 RECEPTOR INHIBITORS TO PATIENTS WITH ACUTE CORONARY SYNDROME: A BENEFIT OR A HARM? |
| title_fullStr | EARLY PRESCRIPTION OF PLATELET P2Y12 RECEPTOR INHIBITORS TO PATIENTS WITH ACUTE CORONARY SYNDROME: A BENEFIT OR A HARM? |
| title_full_unstemmed | EARLY PRESCRIPTION OF PLATELET P2Y12 RECEPTOR INHIBITORS TO PATIENTS WITH ACUTE CORONARY SYNDROME: A BENEFIT OR A HARM? |
| title_short | EARLY PRESCRIPTION OF PLATELET P2Y12 RECEPTOR INHIBITORS TO PATIENTS WITH ACUTE CORONARY SYNDROME: A BENEFIT OR A HARM? |
| title_sort | early prescription of platelet p2y12 receptor inhibitors to patients with acute coronary syndrome a benefit or a harm |
| topic | острый коронарный синдром ингибиторы p2y12-рецепторов тромбоцитов клопидогрел тикагрелор прасугрел |
| url | https://www.aterotromboz.ru/jour/article/view/168 |
| work_keys_str_mv | AT romanmshakhnovich earlyprescriptionofplateletp2y12receptorinhibitorstopatientswithacutecoronarysyndromeabenefitoraharm |